Logotype for Legacy Education Inc

Legacy Education (LGCY) Q3 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Legacy Education Inc

Q3 2025 earnings summary

9 Jul, 2026

Executive summary

  • Achieved record Q3 2025 with 50.7% revenue growth to $18.6 million and a 49.8% increase in enrollment to 3,245 students, driven by strong demand, strategic focus, and the acquisition of Contra Costa Medical Career College (CCMCC), which contributed 468 students.

  • Net income for Q3 2025 rose to $2.8 million, with adjusted EBITDA of $3.9 million and diluted EPS of $0.21; for the nine months ended March 31, 2025, net income was $6.3 million and diluted EPS was $0.51.

  • Completed IPO in September 2024, raising $10 million plus $1.5 million from an over-allotment option, and implemented a 1-for-2 reverse stock split.

  • Maintained high educational outcomes, including an 83% nursing NCLEX pass rate and placement rates of 75% and 76%.

  • Operates six nationally accredited campuses in California, focusing on allied healthcare, veterinary, and business programs.

Financial highlights

  • Q3 2025 revenue reached $18.6 million, up 50.7% year-over-year; nine-month revenue was $46.2 million, up 39% year-over-year.

  • Net income for the nine months ended March 31, 2025 was $6.3 million, up from $4.2 million in the prior-year period.

  • Adjusted EBITDA for Q3 was $3.9 million, and for the last twelve months was $11.4 million, a 170% increase year-over-year.

  • Cash and cash equivalents stood at $17.3 million as of March 31, 2025, with $22 million in working capital and minimal debt of $1 million.

  • Student acquisition cost for Q3 2025 was $1,000, with annual revenue per student at $22,000.

Outlook and guidance

  • Strategic priorities include driving enrollment growth, expanding program offerings, optimizing operational efficiency, and pursuing accretive acquisitions.

  • Management expects continued strong enrollment trends and sufficient liquidity for ongoing operations and planned capital expenditures for at least the next 12 months.

  • New programs in sterile processing, surgical technician, and EMT are being launched.

  • Seasonality expected to impact Q4, with Q1 and Q3 typically being the strongest quarters.

  • Management expects to leverage scale and efficiencies to sustain profitability.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more